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Abstract
Background: Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to
safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile
for OCV reflects increasing priority for use of cholera vaccines in endemic settings. Community acceptance of
vaccines, however, is critical and sociocultural features of acceptance require attention for effective implementation.
This study identifies and compares sociocultural determinants of anticipated OCV acceptance across populations in
Southeastern Democratic Republic of Congo, Western Kenya and Zanzibar.
Methods: Cross-sectional studies were conducted using similar but locally-adapted semistructured interviews
among 1095 respondents in three African settings. Logistic regression models identified sociocultural determinants
of OCV acceptance from these studies in endemic areas of Southeastern Democratic Republic of Congo (SE-DRC),
Western Kenya (W-Kenya) and Zanzibar. Meta-analytic techniques highlighted common and distinctive determinants
in the three settings.
Results: Anticipated OCV acceptance was high in all settings. More than 93 % of community respondents overall
indicated interest in a no-cost vaccine. Higher anticipated acceptance was observed in areas with less access to public
health facilities. In all settings awareness of cholera prevention methods (safe food consumption and garbage disposal)
and relating ingestion to cholera causation were associated with greater acceptance. Higher age, larger households,
lack of education, social vulnerability and knowledge of oral rehydration solution for self-treatment were negatively
associated with anticipated OCV acceptance. Setting-specific determinants of acceptance included reporting a reliable
income (W-Kenya and Zanzibar, not SE-DRC). In SE-DRC, intention to purchase an OCV appeared unrelated to ability to
pay. Rural residents were less likely than urban counterparts to accept an OCV in W-Kenya, but more likely in Zanzibar.
Prayer as a form of self-treatment was associated with vaccine acceptance in SE-DRC and W-Kenya, but not in Zanzibar.
Conclusions: These cholera-endemic African communities are especially interested in no-cost OCVs. Health education
and attention to local social and cultural features of cholera and vaccines would likely increase vaccine coverage. High
demand and absence of insurmountable sociocultural barriers to vaccination with OCVs indicate potential for mass
vaccination in planning for comprehensive control or elimination.
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Background
Cholera results from ingesting pathogenic strains of the
bacterium Vibrio cholerae in contaminated water or food
[1]. Although cholera should not be fatal, if untreated,
case-fatality rates (CFR) for severe cholera may be as
high as 50 % [2]. An estimated 1.4 billion people are at
risk for cholera in endemic countries [3]. Controlling
cholera remains a significant challenge in Sub-Saharan
Africa. Access to safe water and sanitation remain low in
the region, about 61 and 30 %, respectively [4]. Needed
development requires major investments in infrastruc-
ture that proceed very slowly.
In the interim, oral cholera vaccines (OCVs) can save
lives in epidemics and in endemic areas. The World
Health Organization (WHO) recommends OCVs as a
short-term control strategy for high-risk populations to
complement long-term water and sanitation improve-
ments [5]. Two safe OCVs—Shanchol™, with a protective
efficacy of 66 % [6], and Dukoral®, with 79 % direct pro-
tection [7]—are currently available for international
use. Efficacy is not enough, however, for vaccines to
be effective. People must also be willing to accept
them. Local social and cultural ideas about illness,
vaccines and community preferences are critical con-
siderations. Past programme experience provides valu-
able lessons that underscore the priority of social and
cultural aspects of vaccine acceptance and effective
vaccine action [8–11]. A recent review of vaccine
hesitancy suggests community effectiveness may de-
pend on particular features of setting, health problem
and vaccine [12].
Making the benefits of immunization, including new
and underutilized vaccines, available to all regardless of
where they are born, who they are, or where they live is
a vision of the Decade of Vaccines (2011–2020) [13]. In
2012, the World Health Assembly approved the Global
Vaccine Action Plan as a framework to achieve this vi-
sion and a strategic objective of the plan emphasised the
importance of understanding community demand and
trust in vaccines. The decision made by Gavi, the Vac-
cine Alliance (Gavi) to contribute to a global stockpile
for OCVs during 2014–2018 reflects increasing priority
for use of cholera vaccines in endemic settings [14].
However, not enough is known about community ac-
ceptance of OCVs, especially across populations, and
this information is critical for effective vaccine imple-
mentation. Furthermore, although some sociocultural
features may have consistent effects on across settings,
others are specific to particular local settings. Systematic
comparison of local studies clarifies consistent and dis-
tinctive effects of sociocultural factors on vaccine accept-
ance that may not be apparent from findings of the local
studies. This interest motivated the comparative analysis
reported here.
This report presents findings from comparison of
sociocultural determinants of anticipated OCV accept-
ance across the three settings in Sub-Saharan Africa:
Southeastern Democratic Republic of Congo (SE-DRC),
Western Kenya (W-Kenya) and Zanzibar. Studies of
sociocultural aspects of cholera and determinants of an-
ticipated OCV acceptance were undertaken in three
cholera-endemic settings in Africa [15–17]. A compari-
son of sociocultural features of cholera illness experience
and meaning have been reported by Schaetti and col-
leagues [18]. Common and distinctive sociocultural de-
terminants of anticipated OCV acceptance that may
affect uptake and effectiveness of OCVs in cholera-
endemic areas of three countries in Sub-Saharan Africa
are presented in this cross-setting analysis. Knowledge of
comparative community interest and setting-specific
determinants of OCV acceptance, gleaned from cross-
cultural study, can guide policy for effective imple-
mentation of OCV. With the development of a global
stockpile, findings to help guide use of OCVs are
likely to be timely.
Methods
Study setting
In SE-DRC, the study was conducted in Kasenga district
of Katanga province. In W-Kenya, it was conducted in
Kisumu and Siaya districts of Nyanza province, located
on the banks of Lake Victoria. In Zanzibar, a semi-
autonomous part of the United Republic of Tanzania,
study sites were located on Unguja and Pemba Islands.
Study design in the three settings—SE-DRC, W-Kenya
and Zanzibar—were very similar. Zanzibar is the only
one of the three settings where a mass OCV vaccin-
ation was implemented [7], but study data analysed
here were collected before the mass vaccination. Rural
and urban (or peri-urban) sites were included in each
of the settings.
In the years 2008 and 2009 a total of 53,049 cholera
cases were reported to the WHO from DRC, 14,516
cases were reported from Kenya and 10,611 cases for
Tanzania [19, 20]. Reported cholera cases are estimated
to represent only a fraction of the actual cases due to
substantial underreporting [21, 22]. All three settings
lack universal access to safe water and sanitation.
Individual study design and instruments
Three cross-sectional studies among adults in the gen-
eral population were conducted. Similar, but locally
adapted, semi-structured EMIC (Explanatory Model
Interview Catalogue) interviews [23] that collected quan-
titative and narrative data were used at each setting. In-
terviews were translated into Kiswahili in all three
settings and additionally into Dholuo for W-Kenya and
CiBemba for SE-DRC. While interview questions were
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nearly identical in all settings, categories for coding were
adapted based on pilot interviews, discussions with local
public health professionals and ethnographic studies in
each of the settings. Interview questions enquired about
sociocultural concepts such as patterns of distress, per-
ceived causes, help-seeking and methods of prevention
associated with a cholera-like illness (presented to re-
spondents using a clinical vignette describing a person
with cardinal cholera symptoms) based on a cultural epi-
demiological framework [24]. Cultural epidemiology
integrates the local validity of anthropology with the ex-
planatory power of epidemiology through a mix of qualita-
tive and quantitative research methods. Sociodemographic
data and respondent ideas about vulnerability to the
illness and associated stigma were also collected.
The instruments also included an assessment of re-
spondents’ willingness to accept OCVs at different
prices: ‘free’ as in the case of many mass vaccination
campaigns; ‘low price’, approximately USD 1; ‘medium
price’, USD 4–5 and ‘high price’, USD 8–11. The differing
price levels were included to assess relative priority for
OCVs in these communities. Four separate questions
were posed to respondents for each of the price levels as
follows: “If a vaccine that you swallow becomes available
to prevent cholera, would you take it if it was made
available [without charge/at price stated in local cur-
rency]”. Responses were recorded on a four -point Likert
scale: ‘yes’, ‘possibly’, ‘uncertain’ and ‘no’. OCV prices were
stated in the near-equivalent local currency as price per
vaccine course. Overall, the instruments enabled assess-
ment of locally-valid distributions of community ideas
regarding cholera experience, meaning and behaviour, in
the absence of an outbreak, and determined anticipated
acceptance of OCVs in all three study settings. The
EMIC interviews used in each of the settings have been
presented by Schaetti et al. [18].
Interviews were revised after pilot-testing. Men and
women from the general population, above 18 years of
age, and physically and mentally able to participate in an
interview that lasted approximately 45 min to one hour
were included.
Sampling and data collection
A minimum sample size of 328 was required in each of
the study settings to enable cross-site comparisons with
95 % significance and 80 % power. Selection of house-
holds for interview in Zanzibar consisted of a simple
random sample at the peri-urban and rural sites, drawn
from geographic information system data and census in-
formation, respectively. In W-Kenya and SE-DRC, where
only estimates of population size were available, sam-
pling was based on household lists obtained through
community health workers or every nth household was
selected systematically based on a random walk method.
Interviews were conducted by locally-recruited inter-
viewers fluent in the local language and English. They
received extensive training in sampling procedures,
obtaining informed consent and interviewing in work-
shops prior to onset of the main study. Data collection
proceeded from June through August 2008 in Zanzibar,
March through May 2010 in Kenya, and August through
September 2010 in SE-DRC. Further details on sampling
and data collection are provided elsewhere [15–17, 25].
Data management and approach to analysis
Quantitative data were double entered using EpiInfo
software version 3.5.1 (Centers for Disease Control and
Prevention, USA).
Explanatory variables
In each setting, prominence means were calculated for
sociocultural variables (e.g., categories of distress and
perceived causes) depending on how they were reported.
A category reported spontaneously by the respondent in
response to an open question received a higher promin-
ence (value = 2) than responses provided only on prob-
ing (value = 1); if a category was identified as most
important among all categories, a value of 3 was added.
The cumulative prominence by respondent (range 0–5)
was used to calculate mean prominence for each cat-
egory. Mean prominence, which encompasses more in-
formation than a mere ‘yes’ or ‘no’ by considering the
degree of relevance of the category, was used in analysis.
SAS statistical software, version 9.2 (SAS Institute Inc.,
USA), was used.
Outcome variables
Anticipated OCV acceptance for free and at the low,
medium and high prices were dichotomized into out-
come variables denoting anticipated OCV acceptance or
non-acceptance.
Logistic regression analysis and meta-analytic techniques
First, for each setting, univariable logistic regressions
were done to identify sociocultural and sociodemo-
graphic determinants of anticipated OCV acceptance.
Anticipated OCV acceptance at each price level served
as outcome variables.
As a next step, meta-analytic techniques were
employed to combine and compare associations between
OCV acceptance and explanatory variables in the three
settings. Meta-analysis refers to statistical methods for
combining and contrasting results from two or more
separate studies in order to identify patterns through
increased statistical power and improved precision [26]. In
this analysis, sociocultural and sociodemographic variables
with consistent combined estimates (p < 0.1) and lacking
heterogeneity (p > 0.1) were selected. Sociocultural variables
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were individually adjusted for sociodemographic variables
from this selection. A fixed-effects meta-analysis of the
adjusted estimates was done, and results are presented in
forest plots, generated using STATA, version 10.1 (StatCorp
LP, TX, USA). Figures 2 and 3 in this report display mul-
tiple forest plots, and each is an individual model. It was
ensured that none of the models were over-fitted. Variables
whose association with anticipated OCV acceptance
showed heterogeneity at a level of p < 0.1 between the
settings and a significant association in at least one of the
settings (p < 0.05) are presented in tables. These variables
were not meta-analysed owing to significant heterogeneity,
but nevertheless provide valuable information regarding
features of OCV acceptance unique to each setting.
Qualitative data were used to help explain quantitative
associations. Narratives were written down in the re-
spective local languages during the interview. They were
then translated into English and typed in a word proces-
sor software using a pre-coded structure that reflected
interview items. Transcripts of narratives were imported
into MAXQDA 10 (Verbi software, Germany) and were
coded using a deductive approach. Numeric explanatory
and outcome variables were also imported into the
MAXQDA data set, enabling selective retrieval of narra-
tives based on identified quantitative relationships.
Ethics statement
Ethical approval was obtained from the Ministry of
Health Ethics Committee of Zanzibar for the study con-
ducted in Zanzibar, Kenya Medical Research Institute
for the study in W-Kenya and from the University of
Kinshasa for the study conducted in SE-DRC. Further-
more, ethical approval was obtained for all three studies
from the WHO Research Ethics Review Committee. All
participants provided written informed consent before
they were interviewed.
Results
Data from a total of 1095 respondents were ana-
lysed—360 from SE-DRC, 379 from W-Kenya and 356
from Zanzibar. Approximately half the respondents in
each of the settings were women. Mean age of respon-
dents was similar in all three settings: 32.8 years in W-
Kenya, 35.5 years in Zanzibar and 38.5 years in SE-DRC.
Average household size was highest in Zanzibar,
followed by SE-DRC and lowest in W-Kenya, with 6.8,
6.2 and 4.5 persons per household, respectively. A reli-
able and dependable income was reported by 35.3 % in
SE-DRC, 47.8 % in W-Kenya and 55.9 % in Zanzibar. In
W-Kenya and SE-DRC, 87.8 and 87.5 %, respectively, re-
ported completing primary or secondary school educa-
tion, while in Zanzibar 68.6 % had completed primary or
secondary school. Most respondents in W-Kenya and
SE-DRC reported Christianity as their religion, while in
Zanzibar respondents were predominantly Muslim. The
most commonly reported occupation in all three settings
was agriculture (30.6 % in Zanzibar and SE-DRC, 26.6 %
in W-Kenya). Further details on sample characteristics
have been presented elsewhere [15, 17, 27].
Anticipated OCV acceptance
High anticipated OCV acceptance rates (>93 %) were
found in all settings when offered for free (Fig. 1), and
acceptance decreased with increasing price. W-Kenya
had the highest number of respondents willing to take
the low-price and no-cost vaccine, while SE-DRC had
the greatest number willing to purchase the medium-
price and high-price OCVs. Zanzibar had the lowest
anticipated OCV acceptance at all prices.
Common determinants of OCV acceptance across all
three settings
Near universal (>95 %) anticipated acceptance reported
for the no-cost and low price OCV at some sites, made
it unnecessary to further consider determinants at these
price-levels. The medium price (USD 4–5) model ap-
proximates the cost for a full-course of Shanchol™ (USD
1.85 per dose [28, 29] = USD 3.70 for 2 doses). The high
price (USD 8–10) model reflects the cost of Shanchol
along with other programmatic and indirect costs. The
high price also crudely approximates the market price
for Dukoral™ (USD 5.25 per dose [28]), which was used
for mass vaccination in Zanzibar.
Sociodemographic determinants
Similar sociodemographic variables were significantly as-
sociated with anticipated OCV acceptance at the
medium price of USD 4–5 (Fig. 2) and high price of
USD 8–11 (Fig. 3). Increasing age and living in a larger
household were associated with decreasing willingness
to accept an OCV. Lack of education was a predictor of
OCV non-acceptance at the high price. It was marginally
significant at the medium price (p = 0.06, not repre-
sented in Fig. 2).
Sociocultural determinants
Sociocultural variables associated with anticipated OCV
acceptance at the medium price were distinct from the
high price. Only two were significantly associated at the
high price, compared to six at the medium price. The
following sociocultural determinants were common to
all settings:
Attention to garbage disposal and consumption of safe
food as measures to prevent cholera were predictors of
OCV acceptance (Fig. 2).
Those identifying worms (Fig. 3) or the cultural prac-
tice of eating soil (Fig. 2) as causes of cholera were more
likely to accept OCVs. Narrative accounts related the
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practice of eating soil to the fact that it is unclean,
even though the practice may be culturally acceptable,
especially for women. Eating unhygienic substances
produced worms in the stomach. Respondents ex-
plained that they were trapped in an unclean environ-
ment, and though aware of the importance of
hygiene, they felt there was little they could do to
prevent cholera.
Knowledge of ORS for home-treatment of cholera was
negatively associated with OCV acceptance at the high
price (Fig. 3).
Identification of physical symptoms of dehydration
such as loose skin and confused thinking were negatively
associated with OCV acceptance (Fig. 2).
Social vulnerability
Respondents with more prominent concern about the
effects of cholera on social relationships with others
were less likely to anticipate purchasing OCV in all set-
tings. The association was clearest in SE-DRC (Fig. 2).
Setting-specific determinants of OCV acceptance
Sociocultural features of vaccine acceptance that
were significantly heterogeneous across the three set-
tings at the medium and high prices are presented in
Tables 1 and 2.
SE-DRC
In SE-DRC, additional aspects of social vulnerability
were apparent. ‘Fear of infecting others’ and ‘interference
of cholera with work and daily activities’ were negatively
associated with high-price OCV acceptance. These issues
indicate a link between social vulnerability and lack of
confidence in ability to pay for an OCV in SE-DRC. Psy-
chological and personal emotional impact of cholera
with reference to sadness and anxiety, on the other
hand, was positively associated with OCV acceptance at
the high price.
Zanzibar
Acknowledging the social disapproval of others in re-
sponse to cholera was positively associated with accept-
ance of the medium-price vaccine in Zanzibar. Another
cultural meaning of cholera, however—witchcraft as a
perceived cause—was associated with non-acceptance of
the medium-price OCV. Prayer was significantly associ-
ated with high-price OCV acceptance at both SE-DRC
and W-Kenya, but not Zanzibar.
W-Kenya
Reporting a regular and dependable household in-
come was positively associated with OCV acceptance
in W-Kenya and Zanzibar. Narratives in W-Kenya in-
cluded repeated community requests for a no-cost
vaccine to provide access to everyone [15]. In W-
97
.2
93
.6
80
.8
67
.5
98
.7
95
.3
72
.8
58
.8
93
.5
60
.7
19
.4
15
.2
0
10
20
30
40
50
60
70
80
90
100
Free Low Medium High
A
n
ti
ci
p
at
ed
 A
cc
ep
ta
n
ce
 
(%
)
OCV Price
SE-DRC, n= 360
W-Kenya, n= 379
Zanzibar, n= 356
Fig. 1 Anticipated oral cholera vaccine acceptance rates in three African settings at different price levels. OCV prices were stated to respondents
in the local currency which was approximately equal to USD 1 (low price), USD 4–5 (medium price) and USD 8–11 (high price). Y-axis denotes
percentage of respondents who provided an affirmative response when asked whether they would be likely to purchase the vaccine at the stated
price. OCV: Oral cholera vaccine; SE-DRC: Southeastern Democratic Republic of Congo; W-Kenya: Western Kenya
Sundaram et al. BMC Public Health  (2016) 16:36 Page 5 of 11
SD: Age (+10 years)
SE-DRC
W-Kenya
Zanzibar
Combined
SD: Household size (+2 persons)
SE-DRC
W-Kenya
Zanzibar
Combined
PC: Eating soil
SE-DRC
W-Kenya
Zanzibar
Combined
SI: Affects social relationships
SE-DRC
W-Kenya
Zanzibar
Combined
PS: Loose skin
SE-DRC
W-Kenya
Zanzibar
Combined
PS: Confused thinking
SE-DRC
W-Kenya
Zanzibar
Combined
WP: Consuming safe food
SE-DRC
W-Kenya
Zanzibar
Combined
WP: Safe garbage disposal
SE-DRC
W-Kenya
Zanzibar
Combined
Setting
-0.07 (-0.27, 0.14)
-0.20 (-0.40, -0.01)
-0.07 (-0.27, 0.14)
-0.12 (-0.23, 0.00)
-0.13 (-0.29, 0.04)
-0.15 (-0.35, 0.04)
-0.14 (-0.32, 0.05)
-0.14 (-0.24, -0.03)
0.30 (-0.15, 0.74)
0.24 (-0.23, 0.71)
0.32 (-0.22, 0.85)
0.28 (0.01, 0.56)
-0.32 (-0.58, -0.07)
-0.08 (-0.32, 0.16)
-0.33 (-0.66, -0.01)
-0.23 (-0.38, -0.07)
-0.51 (-0.92, -0.10)
-0.29 (-0.71, 0.14)
-0.18 (-0.63, 0.26)
-0.34 (-0.58, -0.09)
-0.33 (-0.79, 0.13)
-0.39 (-0.75, -0.02)
0.01 (-0.43, 0.45)
-0.25 (-0.49, -0.01)
0.25 (-0.03, 0.53)
0.09 (-0.20, 0.37)
0.16 (-0.10, 0.43)
0.17 (0.01, 0.33)
0.23 (-0.04, 0.50)
0.16 (-0.11, 0.42)
0.13 (-0.09, 0.35)
0.17 (0.02, 0.31)
Estimate (95% CI)a
OCV non-acceptance  OCV acceptance 
0-1 -.5 .5 1
Fig. 2 Sociocultural determinants of anticipated OCV acceptance at USD 4–5 (medium price) common to all settings. Forest plots depict the
influence of sociodemographic and sociocultural variables on anticipated oral cholera vaccine acceptance at the medium price (USD 4–5) in three
African settings. The weight of the study from each setting is represented by the area of the box whose centre represents the point estimate of effect
from that study. The combined summary estimate of all three studies is represented by the centre of the diamond figure whose left and right extremes
represent the corresponding confidence interval. a Logistic regression coefficient with 95 % confidence interval. Estimates have been adjusted for
significant sociodemographic features (age, education, household size and occupation). SD: Sociodemographics; PC: Perceived causes of cholera;
SI: Social impact of cholera; PS: Physical symptoms identified for cholera; WP: Ways to prevent cholera; OCV: Oral cholera vaccine; SE-DRC: Southeastern
Democratic Republic of Congo; W-Kenya: Western Kenya
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Kenya, acceptance was less in the rural site for both
medium- and high-priced OCVs.
Discussion
Experience with OCV in vaccination campaigns has
been steadily increasing [30]. To the best of our know-
ledge, this analysis is the first review of common and
distinctive sociocultural determinants of anticipated
OCV acceptance across multiple settings in Africa. Com-
parable research methods enabled a systematic meta-
analytic approach. The findings identified patterns that
would be unapparent in the individual studies, such as
the identification of relevant determinants in all three
populations. For example, the finding that knowledge of
ORS for home-treatment of cholera was negatively asso-
ciated with OCV acceptance at the high price was a
unique finding from this meta-analysis, and it was not
apparent (significant) from any of the individual
country-specific studies. Our analysis is based on a sys-
tematic comparison of the three data sets, rather than a
simple comparison of summary findings reported in the
three published papers. The quantitative associations,
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Fig. 3 Sociocultural determinants of anticipated OCV acceptance at USD 8–11 (high price) common to all settings. Forest plots depict the
influence of sociodemographic and sociocultural variables on anticipated oral cholera vaccine acceptance at the high price (USD 8–11) in three
African settings. The weight of the study from each setting is represented by the area of the box whose centre represents the point estimate
of effect from that study. The combined summary estimate of all three studies is represented by the centre of the diamond figure whose left
and right extremes represent the corresponding confidence interval. a Logistic regression coefficient with 95 % confidence interval. Estimates
have been adjusted for significant sociodemographic features (age, education, household size, sex and occupation). SD: Sociodemographics;
PC: Perceived causes of cholera; HT: Home-based treatment, anticipated use of oral rehydration solution as a first-step at home in treating cholera;
OCV: Oral cholera vaccine; SE-DRC: Southeastern Democratic Republic of Congo; W-Kenya: Western Kenya
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derived and presented through forest plots, show how
priority symptoms, perceived causes and options for
help-seeking may influence OCV acceptance positively
or negatively across different populations. Some factors
have common effects across populations and others are
setting-specific, indicating the value of local study to
enable locally effective vaccine action. Although our
methods are not a traditional meta-analysis, use of
meta-analytic techniques highlight key sociocultural
determinants common to three African settings and the
importance of studying them.
Although anticipated acceptance may not perfectly
reflect actual acceptance, observed priority for OCVs
indicate that these communities desire benefits from
such vaccination initiatives. The finding that fewer deter-
minants of anticipated acceptance were identified for the
high priced vaccine (two), compared with the medium
price (six), clearly shows that increased cost imposes an
economic barrier making other features of acceptance
and demand irrelevant.
Paradoxically, SE-DRC has the greatest number willing
to purchase the medium-price and high-price OCVs.
People in W-Kenya and Zanzibar are economically bet-
ter off as seen from gross domestic product per capita
[31] and self-reported reliability of income among study
respondents [18]. The seeming contradiction of greatest
Table 1 Sociocultural features of OCV acceptance heterogeneous across the three settings at USD 4–5 (medium price)
Featuresa Heterogeneity
p-value
Setting-specific estimates (95 % CI)b
SE-DRC W-Kenya Zanzibar
Vulnerability: Poor perceived more vulnerable 0.048 1.38 (0.18, 2.58) −0.24 (−0.71, 0.23) −0.06 (−0.67, 0.55)
Stigma: Others make patient feel ashamed 0.079 0.08 (−0.18, 0.33) −0.12 (−0.33, 0.08) 0.24 (0.00, 0.48)
Physical symptom: Loss of appetite 0.069 −0.01 (−0.27, 0.25) −0.54 (−0.90, −0.17) −0.13 (−0.58, 0.31)
Physical symptom: Unconsciousness 0.032 −0.26 (−0.47, −0.05) −0.03 (−0.28, 0.22) 0.12 (−0.07, 0.30)
Perceived cause: Witchcraft 0.048 0.24 (−0.11, 0.59) 0.28 (−0.50, 1.06) −0.60 (−1.19, −0.01)c
Regular, dependable income 0.002 −0.21 (−0.75, 0.34) 1.02 (0.53, 1.50) 0.98 (0.39, 1.56)c
Married 0.018 −0.25 (−0.96, 0.46) 0.24 (−0.22, 0.70) 1.37 (0.49, 2.24)c
Rural vs. urban site 0.049 0.11 (−0.42, 0.63) −0.63 (−1.09, −0.17) 0.12 (−0.40, 0.65)
Sociocultural and sociodemographic features that are heterogeneously associated with oral cholera vaccine acceptance across three endemic African settings at
the medium price of USD 4–5
Figures in bold represent associations with p < 0.05 for individual settings
SE-DRC Southeastern Democratic Republic of Congo; W-Kenya Western Kenya
aVariables with heterogeneity (p-value < 0.1) and a significant estimate (p < 0.05) in at least one of the settings are presented. Each row represents an association
of the variable with anticipated OCV acceptance and each row is not adjusted for other variables in the table
bSetting-specific logistic regression coefficient with 95 % confidence interval
cIndividual estimates for Zanzibar have been presented in Schaetti et al. [16]
Table 2 Sociocultural features of OCV acceptance heterogeneous across the three settings at USD 8–11 (high price)
Featuresa Heterogeneity
p-value
Setting-specific estimates (95 % CI)b
SE-DRC W-Kenya Zanzibar
Emotional impact: Sadness, anxiety, worry 0.046 0.18 (0.03, 0.34) −0.14 (−0.35, 0.07) 0.14 (−0.13, 0.40)
Social impact: Fear of infecting others 0.009 −0.33 (−0.57, −0.08) 0.02 (−0.18, 0.22) 0.23 (−0.04, 0.50)c
Social impact: Interference with work/daily activities 0.064 −0.31 (−0.52, −0.10) −0.04 (−0.19, 0.11) 0.01 (−0.19, 0.22)
Physical symptom: Pus in stool 0.033 −0.18 (−0.54, 0.18) 0.08 (−0.24, 0.41) 0.75 (0.15, 1.36)c
Physical symptom: Nausea 0.098 −0.50 (−0.89, −0.1) −0.23 (−0.65, 0.19) 0.31 (−0.31, 0.93)
Home treatment: Prayers 0.008 0.38 (0.13, 0.63) 0.39 (0.09, 0.69) −0.24 (−0.58, 0.11)c
Regular, dependable income <0.001 −0.31 (−0.77, 0.14) 0.92 (0.49, 1.34) 0.94 (0.29, 1.59)c
Married 0.006 −0.45 (−1.05, 0.15) 0.18 (−0.24, 0.60) 1.51 (0.46, 2.56)c
Rural vs. urban site 0.002 −0.03 (−0.47, 0.42) −0.67 (−1.08, −0.25) 0.64 (0.04, 1.23)c
Sociocultural and sociodemographic features that are heterogeneously associated with oral cholera vaccine acceptance across three endemic African settings at
the high price of USD 8–11
Figures in bold represent associations with p < 0.05 for individual settings
SE-DRC Southeastern Democratic Republic of Congo; W-Kenya Western Kenya
aVariables with heterogeneity (p-value < 0.1) and a significant estimate (p < 0.05) in at least one of the settings are presented. Each row represents an association
of the variable with anticipated OCV acceptance and each row is not adjusted for other variables in the table
bSetting-specific logistic regression coefficient with 95 % confidence interval
cIndividual estimates for Zanzibar have been presented in Schaetti et al. [16]
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willingness to purchase OCVs among those with least
economic resources may be explained by the serious
trouble caused by cholera in SE-DRC, where public
health facilities are often inaccessible or non-functional.
Another point worth noting is that vaccines in SE-DRC
are usually provided for free. The ability to pay is often
overestimated when the scenario is hypothetical and re-
spondents do not have to actually make the payment
from their own pockets [32, 33]. The finding indicates
community priority for a desired vaccine, rather than
capacity to pay or prospects for effective uptake at the
high price. Zanzibar has the lowest anticipated OCV
acceptance at all prices. This may be an unintended con-
sequence of a more accessible and effective public health
system there compared to the other settings. Cholera
camps instituted during an outbreak are accessible to
most of the population who anticipate a fairly rapid
response from local authorities [16]. Hence, the priority
to pay for a vaccine may be reduced when timely life-
saving treatment is assumed to be readily available com-
pared with SE-DRC, where such confidence in lacking.
Findings suggest that when vaccine price is high,
motivation to purchase OCV appears low among those
with knowledge of feasible treatment options such as
ORS. Vaccination and ORS seem to be competing inter-
ventions in the public mind. Zwisler et al. [34] found
substantial satisfaction with ORS in treating diarrhoea
among caregivers in Kenya and likely re-use of ORS in
treatment if it had ever been used before. The marginal
value of an OCV that users consider costly may be more
limited in areas where ORS is well-known and widely
used. Furthermore, priority for treatment may be valued
more highly than prevention.
All study respondents were adults, and anticipated
OCV acceptance was higher among younger adults. Lack
of education in our study was associated with OCV non-
acceptance. Other studies report a significant positive
association between education and cholera-related
knowledge [35]. Youth and better educated community
residents may be a resource for vaccination campaigns
to mobilize for community awareness of the benefits of
vaccines.
Household size imposes economic constraints; more
mouths to feed leaves less money available for other
expenses, even if desired, including vaccines. OCVs are
especially important for larger households which are
more likely to be crowded and burdened by limited sani-
tation. Sharing a latrine with many households is a
reported risk factor for cholera in Kenya [36]. Economic
limitations affecting the most vulnerable segments of the
community with the least resources highlights the prior-
ity of making OCVs available without cost to users. If
provided at a low price, incentives or discounts for larger
families may increase vaccine uptake.
Contrary to expectations, knowledge of dehydration
symptoms decreased the priority of OCVs for preven-
tion. Symptoms of dehydration, which are clearly related
to cholera for health professionals, do not seem to be
core features of a vaccine-preventable formulation of
cholera in the community. Symptoms of dehydration
may be linked in local perceptions to other forms of
diarrhoea making a “cholera” vaccine less relevant.
Although most respondents in the three studies identi-
fied the illness of the vignette as cholera or its local lan-
guage equivalent (>85 %) [15, 17, 27], its link to
dehydration appears less well understood.
In SE-DRC, social and economic vulnerability are in-
terrelated, and both may constrain access to vaccines for
those who may need it most. In Zanzibar, cholera-
related stigma appears to motivate OCV acceptance, pre-
sumably to avoid stigma. However, vaccine acceptance
was impeded by local magico-religious ideas, possibly
reflecting a conflict between public health and interests
of local healers.
In Zanzibar, religious influences appear less enabling
for OCV acceptance. Although no active resistance from
religious leaders is foreseen in Zanzibar, engaging reli-
gious leaders for vaccine action in all settings is import-
ant to build alliances and pre-empt opposition that may
affect uptake [37], as indicated by notable opposition to
polio vaccines in Nigeria [9, 38]. On the other hand,
prayer and religious influences of a predominantly
Christian population in SE-DRC and W-Kenya may pro-
mote vaccine use.
In W-Kenya, lower anticipated acceptance at the rural
compared to the urban site, may result from urban–rural
income disparities in W-Kenya, which was the only set-
ting where fewer rural than urban respondents reported
reliable and dependable incomes (p < 0.001) [15]. Access
and uptake would appear to be more sensitive there to
the effect of price. In Zanzibar, however, rural respon-
dents were more likely to accept the high-price OCV.
These findings suggest that urban–rural differences in
vaccine acceptance may vary across settings based on
local conditions and priorities.
Limitations and strengths
Data for this analysis were collected between 2008 and
2010 during a period of high cholera burden in all three
settings. More recent WHO data indicate a persisting
cholera burden in DRC (33,661 cases). In United Repub-
lic of Tanzania however, fewer cases (286) were reported,
and in Kenya no cases of cholera were reported in 2012
[39]. The decline in cholera cases in Kenya was attrib-
uted to effectiveness of water, sanitation and hygiene
(WASH) interventions by public health officials (Per-
sonal communication, Public Health Officials in Kisumu
and Siaya. Conversations during a dissemination activity
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conducted by the research team at study sites in West-
ern Kenya, 2013). More recently, however, rapid spread
of cholera has been noted in Kenya with 3301 cases re-
ported between December 2014 and May 2015 [40].
High CFR of 2 % have been noted country-wide with
some counties reporting CFR as high as 7.6 %. Zanzibar
appears to have benefitted from the OCV campaign that
was undertaken there. Thus, priority for use of OCVs
changes with the change in cholera epidemiology. While
OCVs are not indicated in settings with no more cholera,
findings of this study and community priority for prevent-
ing cholera remain relevant not only for consideration in
future outbreaks but also for implementation of other
WASH interventions. Findings and the approach pre-
sented in this comparative analysis are relevant for settings
where there is a clear rationale for use of OCVs.
Although detailed narrative data were collected during
interviews that lasted approximately one hour, sample
size was a limitation in the quantitative analysis. Due to
practical constraints, between 356 and 379 interviews
could be conducted in each setting. The sample size
allowed for limited adjustment and all explanatory vari-
ables could not be adjusted against each other.
In addition to the benefits of increased power through
meta-analytic techniques that enable identification of de-
terminants that may not be apparent in individual stud-
ies, a major strength of this cross-setting analysis is the
identification of sociocultural determinants of OCV ac-
ceptance that are generalizable across multiple popula-
tions. Local study is necessary to understand nuances of
vaccine acceptance or hesitancy that are influenced by
local culture and context. However, questions of
generalizability of findings to other settings often arise. By
considering sociocultural determinants of anticipated
OCV acceptance from local study, but common across
three distinct populations, broader and more generalizable
determinants have been distilled that are useful in guiding
policy for wider use and implementation of OCVs by na-
tional and global policy makers and public health
professionals.
Recent developments towards setting up of a global
stockpile for OCVs is based on the assumption that it
would be used by the populations it is given to. The
approach presented in this study, which makes it pos-
sible to distinguish common and setting-specific socio-
cultural factors affecting OCV acceptance is especially
timely in view of opportunities arising for effective use
of OCVs enabled by the development of a global stockpile.
It is also relevant for enhancing coverage of other vaccines
through consideration of community determinants.
The community perspective is relevant not only for
OCVs but also for consideration of community-related
determinants of vaccine effectiveness, such as hesitancy,
demand and access. A rapid assessment of such
community interests can be expected to contribute to
the effectiveness of vaccine action. Based on experience
with this approach for community assessment, develop-
ment and validation of rapid assessment tools are
needed to demonstrate the usefulness of the approach
for enhancing uptake in programme settings.
Conclusion
The identified sociocultural determinants of OCV ac-
ceptance show that cost constraints are an essential con-
sideration for effective use of OCVs. Paradoxically,
awareness and appreciation of the value of treatment
with ORS was associated with less enthusiasm for the
OCV, and the setting with best prospects for treatment
showed least interest in prevention with OCV. Findings
indicated community interest and demand for cholera
interventions. The absence of major sociocultural bar-
riers to vaccination with OCVs suggest good prospects
for translating vaccine efficacy into programme effective-
ness in epidemic and endemic settings where vaccines
have a role to play in control and elimination of cholera.
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